Panel Summaries from Optimum’s 14th Annual Healthcare Investor Conference 2022
For those that were unable to attend on Optimum’s 14th Annual Healthcare Investor Conference, or indeed would like a recap of what was shared on the day, we have been releasing the top takeaways from the panels!
Our first panel of the day, chaired by Stephen Hansen, from BioCentury, saw a panel of blue chip private investors discussing the sustainability of the huge investment inflows that we have seen in recent years in a panel entitled: ‘Can private markets continue to drive development in Life Sciences?’
This was followed by a brilliant fireside chat between Mike Ward, Head of Thought Leadership at Clarivate, and the legendary Werner Lanthaler, Chief Executive Officer of Evotec, on Werner’s career journey and his approach to building such a successful biotech.
With public markets being particularly difficult at the moment, Hannah Kuchler, Global Pharmaceuticals Correspondent at the Financial Times, chaired an illuminating expert panel entitled ‘Financing Growth: Walking the Tightrope’, discussing what companies should do to secure the finance that is needed to drive innovation and the development of new drugs.
Finally, in times of uncertainty it is always good to hear from those who have been through the cycle a few times before. Just as the good times never last forever, neither do the bad. Amy Brown, Deputy Editor at Evaluate Vantage talked to Daniel Mahony, Entrepreneur-in-Residence and Chair of the BIA, and Gareth Powell, Head of Healthcare at Polar Capital. Dan and Gareth founded the Healthcare Fund at Polar Capital back in 2007 and continue to be the leading investors for our industry. Their panel discussion did not disappoint and was loaded with frank and empowering insights.
Quick Links to our top takeaways:
